Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bybee Clinton
Relationship:   10% Owner
City:   Chicago
State:   IL
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   37,071,986    

Indirect Shares

   66,802,916      
Direct Value   $341,425,405    

Indirect Value

   $762,435,539      
Total Shares   103,874,902      
Total Value   $1,103,860,945      


Illumina Inc $630,463 Kythera Biopharmaceuticals Inc $0 Fate Therapeutics Inc $10,090,607 Agios Pharmaceuticals Inc $101,923,470 Sage Therapeutics, Inc. $0 Juno Therapeutics, Inc. $0 Bellerophon Therapeutics Inc $269,129 Syros Pharmaceuticals, Inc. $23,046,571 Impinj Inc $2,744,624 Denali Therapeutics Inc. $202,668,794 Beam Therapeutics Inc. $51,747 Vir Biotechnology, Inc. $0 Illumina Inc $630,463 Kythera Biopharmaceuticals Inc $0 Fate Therapeutics Inc $10,090,607 Agios Pharmaceuticals Inc $101,923,470 Sage Therapeutics, Inc. $0 Juno Therapeutics, Inc. $0 Bellerophon Therapeutics Inc $269,129 Syros Pharmaceuticals, Inc. $23,046,571 Impinj Inc $2,744,624 Denali Therapeutics Inc. $202,668,794 Beam Therapeutics Inc. $51,747 Vir Biotechnology, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   -1.0   
   0.0   
     Percentage Gain/Loss :
   -18.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Illumina Inc ILMN Former 10% Holder 2004-02-03 5,704 2004-02-03 2,915,298    Premium*  
            Alnylam Pharmaceuticals Inc ALNY 10% Owner 0 2004-05-27 222,500    Premium*  
            Cyclacel Pharmaceuticals Inc CYCC 10% Owner 2004-03-19 0 2004-03-19 2,054,271    Premium*  
            Kythera Biopharmaceuticals Inc KYTH 10% Owner 2012-10-16 2,105,740 2012-10-16 0    Premium*  
            Fate Therapeutics Inc FATE 10% Owner 2013-10-04 2,473,188 2013-10-04 0    Premium*  
            Agios Pharmaceuticals Inc AGIO 10% Owner 2015-02-19 3,088,590 2014-06-23 0    Premium*  
            Sage Therapeutics, Inc. SAGE 10% Owner 2015-06-18 2,124,699 2014-07-23 0    Premium*  
            Juno Therapeutics, Inc. JUNO 10% Owner 2016-03-15 10,552,390 0    Premium*  
            Bellerophon Therapeutics Inc BLPH 10% Owner 2015-02-19 965,660 0    Premium*  
            Xtera Communications, Inc. XCOM Director, 10% Owner 0 2015-11-17 1,885,090    Premium*  
            Syros Pharmaceuticals, Inc. SYRS 10% Owner 2016-07-06 4,637,137 0    Premium*  
            Impinj Inc PI Director 2020-10-23 17,125 2019-11-15 0    Premium*  
            Denali Therapeutics Inc. DNLI 10% Owner 2017-12-12 11,068,749 2017-12-12 0    Premium*  
            Unity Biotechnology Inc UBX 10% Owner 2018-05-07 0 2018-05-07 1,682,417    Premium*  
            Gossamer Bio Inc GOSS 10% Owner 2019-02-12 0 2019-02-12 4,027,958    Premium*  
            Karuna Therapeutics, Inc. KRTX 10% Owner 2019-07-02 0 2019-07-02 1,681,435    Premium*  
            Beam Therapeutics Inc. BEAM 10% Owner 2021-03-31 2,434 2021-03-31 3,521,519    Premium*  
            Vir Biotechnology, Inc. VIR 10% Owner 2022-09-06 30,570 2022-09-06 61,160    Premium*  
            Lyell Immunopharma, Inc. LYEL 10% Owner 2021-06-21 0 2021-06-21 18,206,358    Premium*  
            Neumora Therapeutics, Inc. NMRA 10% Owner 0 2023-12-08 30,544,910    Premium*  
* Premium Members only  

Records found :    115         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ILMN Illumina Inc 10% Owner   –       –       •   2003-11-26 4 D $0.00 $0 I/I (300,001) 3,315,298 -
ILMN Illumina Inc 10% Owner   –       –       •   2003-11-26 4 A $0.00 $0 D/D 463 5,088 -
ILMN Illumina Inc Former 10% Holder   –       –      –    2004-02-03 4 D $0.00 $0 I/I (400,000) 2,915,298 -
ILMN Illumina Inc Former 10% Holder   –       –      –    2004-02-03 4 A $0.00 $0 D/D 616 5,704 -
CYCC Cyclacel Pharmaceuticals ... 10% Owner   –       –       •   2004-03-19 4 B $8.00 $1,500,000 I/I 187,500 2,054,271 1.5 -
CYCC Cyclacel Pharmaceuticals ... 10% Owner   –       –       •   2004-03-19 4 A $0.00 $0 I/I 1,866,771 1,866,771 -
ALNY Alnylam Pharmaceuticals I... 10% Owner   –       –       •   2004-05-27 3 IO $0.00 $0 I/I 0 222,500 -
KYTH Kythera Biopharmaceutical... 10% Owner   –       –       •   2012-10-16 4 A $0.00 $0 D/D 2,030,123 2,030,123 0 -
KYTH Kythera Biopharmaceutical... 10% Owner   –       –       •   2012-10-16 4 OE $7.55 $920,217 D/D 121,883 2,152,006 0 -
KYTH Kythera Biopharmaceutical... 10% Owner   –       –       •   2012-10-16 4 D $19.88 $919,768 D/D (46,266) 2,105,740 0 -
FATE Fate Therapeutics Inc 10% Owner   –       –       •   2013-10-04 4 B $6.00 $4,999,998 D/D 833,333 2,473,188 2.45 -
FATE Fate Therapeutics Inc 10% Owner   –       –       •   2013-10-04 4 A $6.00 $770,682 D/D 128,447 1,639,855 0 -
FATE Fate Therapeutics Inc 10% Owner   –       –       •   2013-10-04 4 A $0.00 $0 D/D 1,511,408 1,511,408 0 -
AGIO Agios Pharmaceuticals Inc 10% Owner   –       –       •   2014-06-23 4 D $0.00 $0 D/D (386,074) 3,474,664 0 -
SAGE Sage Therapeutics, Inc. 10% Owner   –       –       •   2014-07-23 4 A $0.00 $0 D/D 4,249,389 4,249,389 0 -
JUNO Juno Therapeutics, Inc. 10% Owner   –       –       •   2014-12-18 3 IO $0.00 $0 D/D 0 1,097,015 -
JUNO Juno Therapeutics, Inc. 10% Owner   –       –       •   2014-12-23 4 A $0.00 $0 D/D 10,455,375 11,552,390 0 -
SAGE Sage Therapeutics, Inc. 10% Owner   –       –       •   2015-01-14 4 D $0.00 $0 D/D (1,062,345) 3,187,044 0 -
BLPH Bellerophon Therapeutics ... 10% Owner   –       –       •   2015-02-13 3 IO $0.00 $0 D/D 0 752,994 -
AGIO Agios Pharmaceuticals Inc 10% Owner   –       –       •   2015-02-19 4 D $0.00 $0 D/D (386,074) 3,088,590 0 -
BLPH Bellerophon Therapeutics ... 10% Owner   –       –       •   2015-02-19 4 B $12.00 $2,551,992 D/D 212,666 965,660 2.45 -
SAGE Sage Therapeutics, Inc. 10% Owner   –       –       •   2015-06-18 4 D $0.00 $0 D/D (1,062,345) 2,124,699 0 -
XCOM Xtera Communications, Inc... Director   –       •       •   2015-11-12 3 IO $0.00 $0 I/I 0 20,345 -
XCOM Xtera Communications, Inc... Director   –       •       •   2015-11-17 4 A $0.00 $0 I/I 1,564,745 1,885,090 0 -
XCOM Xtera Communications, Inc... Director   –       •       •   2015-11-17 4 B $5.00 $1,500,000 I/I 300,000 1,885,090 2.25 -
  115  Records found
  1  2   3   4   5      
  Page 1 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us